The development and validation of a Turkish insulin treatment self-management scale child form (ages 8-18) and parent form

dc.contributor.authorÖzçelik Ç.Ç.
dc.contributor.authorAktaş E.
dc.contributor.authorCelasin N.Ş.
dc.contributor.authorOkuroğlu G.K.
dc.contributor.authorŞahin Ş.
dc.date.accessioned2024-07-22T08:08:27Z
dc.date.available2024-07-22T08:08:27Z
dc.date.issued2019
dc.description.abstractObjective: The aim of the study was to develop an Insulin Treatment Self-management Scale; both Child Form and Parent Form for children ages 8-18 with type 1 diabetes. Methods: Children with type 1 diabetes and their parents participated in the study. Development of a methodologically designed scale was conducted to investigate insulin treatment self-management of children with type 1 diabetes. Results: A total of 331 children and their parents were recruited. Children and parents completed the data collection tools by themselves. The final scale had two subscales; one was related to cognitive and behavioural expressions regarding insulin treatment (self-efficacy) and the other to emotional aspects of self-maagement of insulin treatment (emotional impacts). The scale was shown to be valid and reliable. Conclusion: This study was a valid and reliable scale for measuring insulin treatment self-management in children with type 1 diabetes. Thus can be used to assess insulin treatment self-management in children with type 1 diabetes and their parents as well as a tool for effective nursing care. © 2019 by Turkish Pediatric Endocrinology and Diabetes Society.
dc.identifier.DOI-ID10.4274/jcrpe.galenos.2019.2019.0026
dc.identifier.issn13085727
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14375
dc.language.isoEnglish
dc.publisherGalenos Yayincilik,
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectAdolescent
dc.subjectBiomarkers
dc.subjectBlood Glucose
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectDiabetes Mellitus, Type 1
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectGlycated Hemoglobin A
dc.subjectHumans
dc.subjectHypoglycemic Agents
dc.subjectInfant
dc.subjectInsulin
dc.subjectMale
dc.subjectParents
dc.subjectPrognosis
dc.subjectSelf Efficacy
dc.subjectSelf-Management
dc.subjectSurveys and Questionnaires
dc.subjectTurkey
dc.subjecthemoglobin A1c
dc.subjectinsulin
dc.subjectantidiabetic agent
dc.subjectbiological marker
dc.subjectglycosylated hemoglobin
dc.subjecthemoglobin A1c protein, human
dc.subjectinsulin
dc.subjectadolescent
dc.subjectArticle
dc.subjectchild
dc.subjectcontent validity
dc.subjectcorrelation analysis
dc.subjectemotion
dc.subjectface validity
dc.subjectfemale
dc.subjecthuman
dc.subjectinsulin dependent diabetes mellitus
dc.subjectLikert scale
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectreliability
dc.subjectsample size
dc.subjectschool child
dc.subjectself care
dc.subjectblood
dc.subjectchild parent relation
dc.subjectfollow up
dc.subjectglucose blood level
dc.subjectinfant
dc.subjectinsulin dependent diabetes mellitus
dc.subjectpreschool child
dc.subjectprognosis
dc.subjectpsychology
dc.subjectquestionnaire
dc.subjectself care
dc.subjectself concept
dc.subjectturkey (bird)
dc.titleThe development and validation of a Turkish insulin treatment self-management scale child form (ages 8-18) and parent form
dc.typeArticle

Files